Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Crizotinib × Clear all

Phase

Status

Completed 4 Active not recruiting 3 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 2 Uveal Melanoma 1 Rare Tumor 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1

Interventions

pembrolizumab 45 Carboplatin 38 Pemetrexed 34 Magnetic Resonance Spectroscopy 33 Specimen Handling 32 Cisplatin 25 Blood Specimen Collection 22 Paclitaxel 15 Radiosurgery 14 durvalumab 13 Radiotherapy 13 Gemcitabine 12 Bevacizumab 12 osimertinib 11 atezolizumab 11 Biopsy 11 Practice Guidelines as Topic 10 Nivolumab 10 Educational Status 9 130-nm albumin-bound paclitaxel 9 X-Rays 8 Standard of Care 8 Immunoglobulin G 8 Docetaxel 8 Surveys and Questionnaires 7 Disulfides 7 Cetuximab 7 Taxes 6 Etoposide 6 Drug Therapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06563999 2024-12-10

NUMER

Sun Yat-sen University

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡